Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
18.30
-0.70 (-3.68%)
May 7, 2026, 2:08 PM EDT - Market open
Stevanato Group Revenue
Stevanato Group had revenue of 273.60M EUR in the quarter ending March 31, 2026, with 6.63% growth. This brings the company's revenue in the last twelve months to 1.20B, up 6.99% year-over-year. In the year 2025, Stevanato Group had annual revenue of 1.19B with 7.45% growth.
Revenue (ttm)
1.20B EUR
Revenue Growth
+6.99%
P/S Ratio
3.53
Revenue / Employee
200,216 EUR
Employees
6,010
Market Cap
5.00B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.19B | 82.24M | 7.45% |
| Dec 31, 2024 | 1.10B | 18.69M | 1.72% |
| Dec 31, 2023 | 1.09B | 101.67M | 10.34% |
| Dec 31, 2022 | 983.68M | 139.76M | 16.56% |
| Dec 31, 2021 | 843.92M | 181.88M | 27.47% |
| Dec 31, 2020 | 662.04M | 125.50M | 23.39% |
| Dec 31, 2019 | 536.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.32B |
| Avantor | 6.55B |
| Bausch + Lomb | 5.10B |
| AptarGroup | 3.87B |
| MiniMed Group | 2.99B |
| Envista Holdings | 2.81B |
| ICU Medical | 2.23B |
| Teleflex | 1.99B |
STVN News
- 5 hours ago - Stevanato Group Earnings Call Transcript: Q1 2026 - Transcripts
- 7 hours ago - Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026 - Business Wire
- 2 days ago - Stevanato Group to Participate in Three Upcoming Investor Conferences - Business Wire
- 13 days ago - Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
- 6 weeks ago - Stevanato Group management to meet with KeyBanc - TheFly
- 7 weeks ago - Stevanato Group Transcript: 2026 KeyBanc Capital Markets Healthcare Forum - Transcripts
- 7 weeks ago - Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum - Business Wire
- 2 months ago - Stevanato Group price target lowered to $19 from $24 at Morgan Stanley - TheFly